Destiny Hinton

See how St. Jude is working to counteract the rise of antifungal resistance

Translational research from Suzanne Baker, PhD, and colleagues shows that targeted MET inhibitor capmatinib effectively crosses the blood-brain-barrier, synergizing with radiation to treat pediatric high-grade glioma.

Explore how St. Jude researchers are tackling the silent pandemic of antibiotic resistance and pioneering the development of new drugs to address the growing threat.

See how the St. Jude BioHackathon solves research problems and builds community. 

Explore how St. Jude has and continues to lead infectious diseases research to prevent infections in children with compromised immune systems. 

Childhood cancer survivors are at an increased risk of major adverse cardiovascular events, making safeguarding heart health a priority.

Find out how Victor Torres, PhD, Department of Host-Microbe Interactions chair, is leading research on antimicrobial resistant pathogens.

Learn how Richard Finkel, MD, is developing the Center for Experimental Neurotherapeutics to be the gold standard in pediatric neurological disease treatment development

Factors like family anxiety and neighborhood adversity contribute to symptom burden in childhood cancer survivors and the need for comprehensive care.

Discover how the National Graduate Student Symposium fosters postdoc recruitment and career growth at St. Jude.